BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24270077)

  • 1. The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Zhao YF; Jiang YP; Zhou LF; Wu XL
    Am J Med Sci; 2014 May; 347(5):393-9. PubMed ID: 24270077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
    Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
    Rammaert B; Verdier N; Cavestri B; Nseir S
    Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
    Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
    Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD assessment test score and serum C-reactive protein levels in stable COPD patients.
    Kang HK; Kim K; Lee H; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3137-3143. PubMed ID: 27994452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary disease.
    Tofan F; Rahimi-Rad MH; Rasmi Y; Rahimirad S
    Pneumologia; 2012; 61(3):160-2. PubMed ID: 23175870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
    Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
    COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
    Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
    Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors of Poor Outcomes after Admission for a COPD Exacerbation: Multivariate Logistic Predictive Models.
    García-Rivero JL; Esquinas C; Barrecheguren M; Bonnin-Vilaplana M; García-Sidro P; Herrejón A; Martinez-Rivera C; Malo de Molina R; Marcos PJ; Mayoralas S; Naval E; Ros JA; Valle M; Miravitlles M
    COPD; 2017 Apr; 14(2):164-169. PubMed ID: 27983876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues.
    Castello LM; Bellan M
    Respir Res; 2018 Mar; 19(1):35. PubMed ID: 29490639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of acute deterioration in health status visit among COPD patients by monitoring COPD assessment test score.
    Pothirat C; Chaiwong W; Limsukon A; Deesomchok A; Liwsrisakun C; Bumroongkit C; Theerakittikul T; Phetsuk N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():277-82. PubMed ID: 25678783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Measurement of Serum Vascular Endothelial Growth Factor in Patients with Chronic Obstructive Pulmonary Disease.
    Boeck L; Mandal J; Costa L; Roth M; Tamm M; Stolz D
    Respiration; 2015; 90(2):97-104. PubMed ID: 26066063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-risk patients following hospitalisation for an acute exacerbation of COPD.
    Piquet J; Chavaillon JM; David P; Martin F; Blanchon F; Roche N;
    Eur Respir J; 2013 Oct; 42(4):946-55. PubMed ID: 23349446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the effectiveness of the COPD Assessment Test (CAT) to evaluate COPD severity and exacerbation rates.
    Varol Y; Ozacar R; Balci G; Usta L; Taymaz Z
    COPD; 2014 Apr; 11(2):221-5. PubMed ID: 24111793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Causes of chronic obstructive pulmonary disease-related death and influencing factors of survival time].
    Chang C; Yao WZ; Fang TS
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):824-7. PubMed ID: 21600162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic value of serum copeptin levels in an acute pulmonary embolism.
    Kalkan AK; Ozturk D; Erturk M; Kalkan ME; Cakmak HA; Oner E; Uzun F; Tasbulak O; Yakisan T; Celik A
    Cardiol J; 2016; 23(1):42-50. PubMed ID: 26711465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.
    Mackay AJ; Donaldson GC; Patel AR; Jones PW; Hurst JR; Wedzicha JA
    Am J Respir Crit Care Med; 2012 Jun; 185(11):1218-24. PubMed ID: 22281834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.